If you are taking PAXIL,
you do not know what trouble you are in or will be if you
try to stop taking the drug. It is extremely addictive. The
following is a review of the literature and foreign labels:
Physicians
in the U.S. are bombarded with marketing messages designed
to minimize concerns surrounding with drawl. For instance,
the pharmaceutical giant, Glaxo-Smith-Kline (GSK) uses the
term “discontinuation syndrome” rather than withdrawl” because
it infers “addictive” qualities. In fact, the term “discontinuation”
is not even a legitimate medical term – it is not listed in
any recognized medical dictionary. GSK's contrived distinction
between “discontinuation” and “withdrawl” is wholly inconsistent
with the language found in foreign labels of Paxil, wherein
GSK acknowledges that Paxil can cause withdrawl symptoms:
Italy :
“Withdrawl symptoms may occur if
treatment is discontinued abruptly. Such symptoms include:
insomnia, dizziness, sweating, palpitations, nausea, anxiety,
irritability, parasthesia, and headache.”
UK :
“Withdrawl symptoms have been reported
on stopping treatment: dizziness, sensory disturbance (e.g.
parasthesia), anxiety, sleep disturbances (including intense
dreams) agitation, tremor, nausea, sweating, and confusion
have been reported following the abrupt withdrawal of ‘Seroxat'
[Paxil].
Ireland
: “Withdrawal reactions
have been reported following discontinuation of ‘Seroxat”
[Paxil], these include dizziness, sensory disturbance (e.g.
parasthesia), anxiety, sleep disturbances (including intense
dreams), agitation, tremor, nausea, sweating, and confusion.
“
Netherlands:
“Abrupt discontinuation of Seroxat therapy must
be avoided as this may result in withdrawl symptoms such as
sleep disturbances, sensory disturbances, dizziness, agitation,
anxiety, sweating, and nausea.
Spain: “Discontinuation
of paroxetine administration (especially if it is abrupt)
may lead to withdrawl symptoms such as dizziness, sensory
disturbances (including parasthesia and sensation of cramps),
headache, sleep disturbances, agitation or anxiety, nausea,
and sweating.”
France :
“abrupt withdrawl of the treatment may cause,
within one week, symptoms such as dizziness, sensory disorders,
sleep disturbances, agitation, anxiety, asthenia, digestive
disorders, and sweating. These signs may persist for 1-2 weeks.
For additional information
concerning Paxil withdrawal, please refer to www.baumhedlundlaw.com/Paxil/paxilupdate.htm
. An interview with Paxil withdrawal suit plaintiff Trisha
Spinelli should also be read: www.counterpunch.org/giombetti0912.html
|